Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Laviana Raises $14 Million for CDMO Operations in China

publication date: Sep 9, 2019

Laviana Pharma of China raised about $14 million in a B+ financing to develop its CDMO operations. Founded in 2005, Laviana offers outsourced process and manufacturing services for pharma companies, especially chemistry-related services. The company has three facilities in China -- Beijing, Tianjin and Taizhou -- plus a business office in the US. The company announced a similar $15 million funding in January 2081. The latest funding was led by V-Capital of Shanghai and included Guangdong's CMW Asset Management. More details....

Stock Symbol: (NEEQ: 838853) 

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China